Search for: "Sandoz, Inc. "
Results 501 - 520
of 599
Sorted by Relevance
|
Sort by Date
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
15 Apr 2010, 4:27 am
Sandoz B.V. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
1 Jul 2009, 7:14 am
(Patent Docs) Products Avapro (Irbesartan) – Spain: Fourth Commercial Court of Barcelona rejects preliminary injunction petition by Sanofi-Aventis and Bristol-Myers Squibb for alleged patent infringement (International Law Office) Cozaar/Hyzaar (Losartan/Hydrochlorothiazide and Losartan) –US: Teva sues FDA over generic Cozaar and Hyzaar 180-day exclusivity forfeiture and patent delisting rule (The FDA Law Blog) Eloxatin (Oxaliplatin) – US: District Court of New Jersey… [read post]
9 Feb 2015, 1:15 am
Now, Darren sinks his paws on the appeal decision in Hospira (UK) Ltd v Genentech, Inc [2015] EWCA Civ 57 (6 February 2015). [read post]
24 Sep 2009, 5:09 am
Bieffe USA, Inc., 35 F. [read post]
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
2 Jun 2011, 12:46 pm
Wyeth Inc., 488 F. [read post]
10 Nov 2017, 9:21 am
Sandoz, Inc., 135 S. [read post]
24 Aug 2012, 4:33 pm
Sandoz, Inc., 678 F.3d 1280, 1290 (Fed. [read post]
12 Jun 2017, 12:15 pm
Thomas has the last opinion of the day, in Sandoz Inc. v. [read post]
11 Jan 2017, 7:19 am
Sandoz Inc. v. [read post]
28 Dec 2012, 1:57 pm
Medtronic, Inc., 670 F.3d 569 (4th Cir. 2012). [read post]
19 Jul 2007, 1:47 pm
Zimmer, Inc., 2004 WL 5254312 (D. [read post]
16 Nov 2012, 1:50 pm
Sharp Memorial Hospital, Inc., 264 Cal. [read post]
19 Mar 2022, 2:09 pm
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
12 Jun 2014, 8:48 pm
Sandoz, Inc., 678 F.3d 1280, 1293 (Fed. [read post]
